Publication Cover
Accountability in Research
Ethics, Integrity and Policy
Volume 15, 2008 - Issue 4
340
Views
7
CrossRef citations to date
0
Altmetric
Original Articles

Biomedical Research and the Commercialization Agenda: A Review of main Considerations for Neuroscience

&
Pages 303-320 | Published online: 29 Oct 2008

References

  • A Triumph of Hype over Experience? . 1995 . The Economist. , 16 December
  • American Association for the Advancement of Science. (2007). International Intellectual Property Experiences: A Report of Four Ccountries. Washington, DC: American Association for the Advancement of Science http://sippi.aaas.org/Pubs/SIPPI_Four_Country_Report.pdf (Accessed: 5 May 2008 ).
  • Andrews , L. B. 2002 . The gene patent dilemma: Balancing commercial incentives with health needs . Houston Journal of Health Law and Policy , 2 : 65 – 106 .
  • Atkinson-Grosjean , J. 2002 . Canadian science at the public/private divide: The NCE experiment . Journal of Canadian Studies , 37 ( 3 ) : 71 – 91 .
  • Ausman , J. I. 2006 . I told you it was going to happen … part II . Surgical Neurology , 65 ( 5 ) May : 520 – 521 .
  • Basky , G. 2001 . Canada's first private genetic testing clinic “highly problematic”: Geneticist . CMAJ , 165 ( 11 ) 27 November : 1524
  • Becerra, X. (2007). Reps. Becerra & Weldon introduce bill to ban the practice of gene patenting http://becerra.house.gov/HoR/CA31/News/Press+Releases/2007/02-09-07+REPS+BECERRA+WELDON+INTRODUCE+BILL+TO+BAN+THE+PRACTICE+OF+GENE+PATENTING.htm (Accessed: 5 May 2008 ).
  • Bekelman , J. E. , Li , Y. and Gross , C. P. 2003 . Scope and impact of financial conflicts of interest in biomedical research: A systematic review . JAMA , 289 ( 4 ) Jan 22–29 : 454 – 465 .
  • Beyleveld , D. and Brownsword , R. 2001 . Human Dignity in Bioethics and Biolaw , Oxford : Oxford University Press .
  • Bloom, P. (2006). Seduced by the flickering lights of the brain. Seed Magazine. 27 June http://seedmagazine.com/news/2006/06/seduced_by_the_flickering_ligh.php (Accessed: 6 May 2008 ).
  • Blumenthal , D. , Campbell , E. G. , Gokhale , M. , Yucel , R. , Clarridge , B. , Hilgartner , S. and Holtzman , N. A. 2006 . Data withholding in genetics and the other life sciences: Prevalences and predictors . Academic Medicine , 81 ( 2 ) Feb : 137 – 145 .
  • Bubela , T. 2006 . Science communication in transition: Genomics hype, public engagement, education and commercialization pressures . Clinical Genetics , 70 ( 5 ) Nov : 445 – 450 .
  • Bubela , T. M. and Caulfield , T. A. 2004 . Do the print media “hype” genetic research? A comparison of newspaper stories and peer-reviewed research papers . CMAJ , 170 ( 9 ) Apr 27 : 1399 – 1407 .
  • Campbell , E. G. , Clarridge , B. R. , Gokhale , M. , Birenbaum , L. , Hilgartner , S. , Holtzman , N. A. and Blumenthal , D. 2002 . Data withholding in academic genetics: Evidence from a national survey . JAMA , 287 ( 4 ) Jan. 23–30 : 473 – 480 .
  • Canada, Standing Committee on Health. (2001). Assisted reproduction: Building families. House of Commons, Canada http://cmte.parl.gc.ca.login.ezproxy.library.ualberta.ca/Content/HOC/committee/371/heal/reports/rp1032041/healrp02/healrp02-e.pdf (Accessed: 5 May 2008 ).
  • Canli , T. , Brandon , S. , Casebeer , W. , Crowley , P. J. , Du Rousseau , D. , Greely , H. T. and Pascual-Leone , A. 2007 . Neuroethics and national security . AJOB , 7 ( 5 ) May : 3 – 13 .
  • Caulfield , T. 2007 . Profit and the production of the knowledge: The impact of industry on representations of research results . Harvard Health Policy Review , 8 : 68 – 77 .
  • Caulfield , T. 2005 . Popular media, biotechnology and the ‘cycle of hype,’ . Journal of Health Law and Policy , 5 : 213 – 233 .
  • Caulfield , T. 2004 . Biotechnology and the popular press: Hype and the selling of science . Trends in Biotechnology , 22 ( 7 ) Jul : 337 – 339 .
  • Caulfield , T. 2003a . Sustainability and the balancing of the health care and innovation agendas: The commercialization of genetic research . Saskatchewan Law Review , 66 ( 2 ) : 629 – 645 .
  • Caulfield , T. 2003b . From human genes to stem cells: New challenges for patent law? . Trends in Biotechnology , 21 ( 3 ) Mar : 101 – 103 .
  • Caulfield , T. 2000 . Underwhelmed: Hyperbole, regulatory policy, and the genetic revolution . McGill Law Journal , 45 : 437 – 460 .
  • Caulfield , T. 1998 . The commercialization of human genetics: A discussion of issues relevant to the Canadian consumer . Journal of Consumer Policy , 21 ( 4 ) : 483 – 526 .
  • Caulfield , T. A. , Knoppers , B. M. , Gold , E. R. , Sheremeta , L. E. and Bridge , P. J. 2003 . Genetic technologies, health care policy and the patent bargain . Clinical Genetics , 63 ( 1 ) Jan : 15 – 18 .
  • Caulfield , T. and Brownsword , R. 2006 . Human dignity: A guide to policy making in the biotechnology era? Nature Reviews . Genetics , 7 ( 1 ) Jan : 72 – 76 .
  • Caulfield , T. and Bubela , T. 2004 . Media representations of genetic discoveries: Hype in the headlines? . Health Law Review , 12 ( 2 ) : 53 – 61 .
  • Caulfield , T. , Cook-Deegan , R. M. , Kieff , F. S. and Walsh , J. P. 2006a . Evidence and anecdotes: An analysis of human gene patenting controversies . Nature Biotechnology , 24 ( 9 ) Sep : 1091 – 1094 .
  • Caulfield , T. , Einsiedel , E. , Merz , J. F. and Nicol , D. 2006b . Trust, patents and public perceptions: The governance of controversial biotechnology research . Nature Biotechnology , 24 ( 11 ) Nov : 1352 – 1354 .
  • Caulfield , T. , Ogbogu , U. , Murdoch , C. J. and Einsiedel , E. 2008 . Patents, commercialization and the Canadian stem cell research community . Regenerative Medicine , 3 ( 4 ) : 483 – 496 .
  • Cho , M. K. 2002 . Conflicts of interest in magnetic resonance imaging: Issues in clinical practice and research . Topics in Magnetic Resonance Imaging , 13 ( 2 ) Apr : 73 – 77 .
  • Cho , M. K. and Bero , L. A. 1996 . The quality of drug studies published in symposium proceedings . Annals of Internal Medicine , 124 : 485
  • Cho , M. K. , Illangasekare , S. , Weaver , M. A. , Leonard , D. G. and Merz , J. F. 2003 . Effects of patents and licenses on the provision of clinical genetic testing services . The Journal of Molecular Diagnostics , 5 ( 1 ) Feb : 3 – 8 .
  • Coles, T. (2008). Genetic testing from the comfort of your home. Reuters, 5 May, 2008 http://www.canada.com/topics/bodyandhealth/story.html?id=544e969c-14cb-4255-bfed-088f82d51607 (Accessed: 6 May 2008 ).
  • Conrad , P. 2001 . Genetic optimism: Framing genes and mental illness in the news . Culture, Medicine and Psychiatry , 25 ( 2 ) Jun : 225 – 247 .
  • Danish Council on Ethics. (2004). Patenting human genes and stem cells. Copenhagen: Danish Council on Ethics http://www.etiskraad.dk/graphics/03_udgivelser/engelske_publikationer/patenting_human_genes/patents04/patenting_human_genes.pdf (Accessed: 5 May 2008 ).
  • Downie , J. and Herder , M. 2007 . Reflections on the commercialization of research conducted in public institutions in Canada . McGill Health Law Publication , 1 : 23 – 44 .
  • Eaton , L. 2005 . BMA warns against unnecessary screening tests in private sector . BMJ , 331 3 September : 475
  • Eaton , M. L. and Illes , J. 2007 . Commercializing cognitive neurotechnology–the ethical terrain . Nature Biotechnology , 25 ( 4 ) Apr : 393 – 397 .
  • Ebers , M. and Powell , W. W. 2007 . Biotechnology: Its origins, organization, and outputs . Research Policy , 36 ( 4 ) : 433 – 437 .
  • Editorial . 2002 . Neuroscience, Inc . Nature Neuroscience , 5 ( 1 ) Jan : 1
  • Einsiedel, E., and Smith, J. (2005). Canadian views on patenting biotechnology. Canadian Biotechnology Advisory Committee http://www.cbac-cccb.ca/epic/site/cbac-cccb.nsf/vwapj/FINAL_inseidel_e.pdf/$FILE/FINAL_inseidel_e.pdf (Accessed: 5 May 2008 ).
  • Federal Trade Commission. (2006). At-home genetic tests: A healthy dose of skepticism may be the best prescription http://www.ftc.gov/bcp/edu/pubs/consumer/health/hea02.pdf (Accessed: 6 May 2008 ).
  • Firlik , A. D. , Lowry , D. W. , Levy , A. J. and Hirsch , R. C. 2000 . The neurosurgeon as innovator and entrepreneur . Neurosurgery , 47 ( 1 ) Jul : 169 – 175 . discussion 175–177.
  • Fisher , D. , Atkinson-Grosjean , J. and House , D. 2001 . Changes in academy/industry/state relations in Canada: The creation and development of the Networks of Centres of Excellence . Minerva , 39 : 299 – 325 .
  • Fitzgerald, M. (2005). VCs psyched over brain investments. Venture Capital Journal (August 1) http://www.atvcapital.com/news.php?id=250 (Accessed: 5 May 2008 ).
  • Fleising , J. 2001 . In search of genohype: A content analysis of biotechnology company documents . New Genetics and Society , 20 ( 3 ) : 239 – 254 .
  • Genetics and Public Policy Center. (2008). Direct-to-consumer genetic testing: Empowering or endangering the public? http://www.dnapolicy.org/images/issuebriefpdfs/2006_DTC_Issue_Brief.pdf (Accessed: 6 May 2008 ).
  • Godin , B. , Doré , C. and Larivière , V. 2002 . The production of knowledge in Canada: Consolidation and diversification . Journal of Canadian Studies , 37 ( 3 ) : 56 – 70 .
  • Gold , R. E. 2003 . “ From theory to practice: Health care and the patent system ” . In Health Law Journal , Special 21 – 39 .
  • Greely , H. T. 2006 . Neuroethics and ELSI: Similarities and differences . Minnesota Journal of Law, Science & Technology , 7 : 599 – 637 .
  • Heller , M. A. and Eisenberg , R. S. 1998 . Can patents deter innovation? The anticommons in biomedical research . Science , 280 ( 5364 ) May 1 : 698 – 701 . (New York, N.Y.)
  • Herder , M. and Brian , J. D. 2008 . Canada's stem cell corporation: Aggregate concerns and the question of public trust . Journal of Business Ethics , 77 ( 1 ) : 73 – 84 .
  • Holtzman , N. A. , Bernhardt , B. A. , Mountcastle-Shah , E. , Rodgers , J. E. , Tambor , E. and Geller , G. 2005 . The quality of media reports on discoveries related to human genetic diseases . Community Genetics , 8 ( 3 ) : 133 – 144 .
  • Hong, W., and Walsh, J. P. (2008). For money or glory? Commercialization, competition and secrecy in the entrepreneurial university, Sociological Quarterly http://smartech.gatech.edu/hande/1853/23032 (Accessed: 5 October 2008 ).
  • Hopkins , M. M. , Martin , P. A. , Nightingale , P. , Kraft , A. and Mahdi , S. 2007 . The myth of the biotech revolution: An assessment of technological, clinical and organisational change . Research Policy , 36 ( 4 ) : 566 – 589 .
  • Human Genetics Commission. (2007a). More genes direct: A report on developments in the availability, marketing and regulation of genetic tests supplied directly to the public. London, UK: Human Genetics Commission http://www.hgc.gov.uk/UploadDocs/DocPub/Document/More%20Genes%20Direct%20-%20final.pdf (Accessed: 6 May 2008 ).
  • Human Genetics Commission. (2007b). Statement on private genetic testing services http://www.hgc.gov.uk/Client/Content.asp?ContentId=793 (Accessed: 6 May 2008 ).
  • Human Genetics Commission. (2003). Genes direct: Ensuring the effective oversight of genetic tests supplied directly to the public. London, UK: Department of Health http://www.hgc.gov.uk/UploadDocs/DocPub/Document/genesdirect_full.pdf (Accessed: 6 May 2008 ).
  • Hype over experience–Stem cells and business . 2005 . The Economist. , 24 September
  • Illes , J. and Racine , E. 2005 . Imaging or imagining? A neuroethics challenge informed by genetics . AJOB , 5 ( 2 ) Spring : 5 – 18 .
  • Justo , L. and Erazun , F. 2007 . Neuroethics and human rights . AJOB , 7 ( 5 ) May : 16 – 8 .
  • Lau , D. , Ogbogu , U. and Caulfield , T. From legitimate promise to quackery? The market for stem cell therapies. , (Content analysis of websites offering stem cell based therapies), (submitted).
  • Lemmens , T. 2004 . Leopards in the temple: Restoring scientific integrity to the commercialized research scene . The Journal of Law, Medicine & Ethics , 32 ( 4 ) Winter : 641 – 657 .
  • Mulkay , M. 1994 . Embryos in the news . Public Understanding of Science , 3 : 33 – 51 . (Bristol, England)
  • Murray , F. 2007 . The stem-cell market–Patents and the pursuit of scientific progress . The New England Journal of Medicine , 356 ( 23 ) Jun 7 : 2341 – 2343 .
  • Murray , F. and Stern , S. 2007 . Do formal intellectual property rights hinder the free flow of scientific knowledge? An empirical test of the anti-commons hypothesis . Journal of Economic Behavior & Organization , 63 : 648 – 687 .
  • Nelson , R. R. 2004 . The market economy and the scientific commons . Research Policy , 33 : 455 – 471 .
  • Ogbogu , U. 2008 . The regulation of conflicts of interest in the Canadian stem cell research environment . Health Law Review , 16 ( 2 ) : 41 – 55 .
  • Plomer , A. , Taymor , K. S. and Scott , C. T. 2008 . Challenges to human embryonic stem cell patents . Cell Stem Cell , 2 ( 1 ) Jan : 13 – 17 .
  • Racine , E. , Bar-Ilan , O. and Illes , J. 2005 . fMRI in the public eye . Nature Reviews Neuroscience , 6 ( 2 ) Feb : 159 – 164 .
  • Racine , E. , Bar-Ilan , O. and Illes , J. 2006 . Brain imaging: A decade of coverage in the print media . Science Communication , 28 ( 1 ) : 122 – 143 .
  • Racine , E. and Illes , J. 2006 . Neuroethical responsibilities . The Canadian Journal of Neurological Sciences , 33 ( 3 ) Aug : 269 – 277 .
  • Ransohoff , D. F. and Ransohoff , R. M. 2001 . Sensationalism in the media: When scientists and journalists may be complicit collaborators . Effective Clinical Practice , 4 ( 4 ) Jul-Aug : 185 – 188 .
  • Resnik , D. B. 2007 . Embryonic stem cell patents and human dignity . Health Care Analysis: Journal of Health Philosophy and Policy , 15 ( 3 ) Sep : 211 – 222 .
  • Resnik , D. B. 2003a . Patents on human-animal chimeras and threats to human dignity . AJOB , 3 ( 3 ) Summer : 35 – 36 .
  • Resnik , D. B. 2003b . Are DNA patents bad for medicine? . Health Policy , 65 ( 2 ) Aug : 181197 (Amsterdam, Netherlands)
  • Resnik , D. B. 2002 . The commercialization of human stem cells: Ethical and policy issues . Health Care Analysis: Journal of Health Philosophy and Policy , 10 ( 2 ) : 127 – 154 .
  • Resnik , D. B. 2001 . DNA patents and human dignity . The Journal of Law, Medicine & Ethics , 29 ( 2 ) Summer : 152 – 165 .
  • Ross , J. S. , Hill , K. P. , Egilman , D. S. and Krumholz , H. M. 2008 . Guest authorship and ghostwriting in publications related to Rofecoxib: A case study of industry documents from Rofecoxib litigation . JAMA , 299 ( 15 ) : 1800 – 1812 .
  • Rousche , P. , Schneeweis , D. M. , Perreault , E. J. and Jensen , W. 2008 . Translational neural engineering: Multiple perspectives on bringing benchtop research into the clinical domain . Journal of Neural Engineering , 5 ( 1 ) Mar : P16 – 20 .
  • Sheehy , H. , Legault , M. and Ireland , D. 1998 . Consumers and biotechnology: A synopsis of survey and focus group research . Journal of Consumer Policy , 21 : 359 – 386 .
  • Shuchman , M. and Wilkes , M. S. 1997 . Medical scientists and health news reporting: A case of miscommunication . Annals of Internal Medicine , 126 ( 12 ) Jun 15 : 976 – 982 .
  • Smith , R. 2003 . The screening industry . BMJ , 326 26 April : 0
  • Stelfox , H. T. , Chua , G. , O'Rourke , K. and Detsky , A. S. 1998 . Conflict of interest in the debate over calcium-channel antagonists . The New England Journal of Medicine , 338 ( 2 ) Jan 8 : 101 – 106 .
  • Vogeli , C. , Yucel , R. , Bendavid , E. , Jones , L. M. , Anderson , M. S. , Louis , K. S. and Campbell , E. G. 2006 . Data withholding and the next generation of scientists: Results of a national survey . Academic Medicine , 81 ( 2 ) Feb : 128 – 136 .
  • Vrtovec , K. T. and Scott , C. T. 2008 . Patenting pluripotence: The next battle for stem cell intellectual property . Nature Biotechnology , 26 ( 4 ) Apr : 393 – 395 .
  • Walsh , J. P. , Arora , A. and Cohen , W. M. 2003 . Science and the law. Working through the patent problem . Science , 299 ( 5609 ) Feb 14 : 1021 (New York, N.Y.)
  • Walsh, J. P., Cho, C., and Cohen, W. M. (2005). Patents, material transfers and access to research inputs in biomedical research: Final report to the National Academy of Sciences' Committee on Intellectual Property Rights in Genomic and Protein-related Inventions. National Academy of Sciences. http://www2.druid.dk/conferences/viewpaper.php?id=776&cf=8 (Accessed: 5 October 2008 ).
  • Walsh , J. P. , Cohen , W. M. and Cho , C. 2007 . Where excludability matters: Material versus intellectual property in academic biomedical research . Research Policy , 36 : 1184 – 1203 .
  • Weisberg , D. S. , Keil , F. C. , Goodstein , J. , Rawson , E. and Gray , J. R. 2008 . The seductive allure of neuroscience explanations . Journal of Cognitive Neuroscience , 20 ( 3 ) Mar : 470 – 477 .
  • Wilkes , M. S. and Kravitz , R. L. 1992 . Medical researchers and the media. Attitudes toward public dissemination of research . JAMA , 268 ( 8 ) Aug 26 : 999 – 1003 .
  • Williams-Jones , B. 2006 . ‘Be ready against cancer, now’: Direct-to-consumer advertising for genetic testing . New Genetics & Society , 25 ( 1 ) : 89 – 107 .
  • Williams-Jones , B. and Corrigan , O. P. 2003 . Rhetoric and hype: Where's the ‘ethics’ in pharmacogenomics? . American Journal of Pharmacogenomics: Genomics-Related Research in Drug Development and Clinical Practice , 3 ( 6 ) : 375 – 383 .
  • Wolpe , P. R. , Foster , K. R. and Langleben , D. D. 2005 . Emerging neurotechnologies for lie-detection: Promises and perils . AJOB , 5 ( 2 ) Spring : 39 – 49 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.